Trinity Biotech acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments. The company offers tests for infectious diseases, viral pathogens, diabetes monitoring, and autoimmune disorders. Products are sold through a direct sales force and independent distributors. Trinity Biotech also provides reagent products for liver and kidney disease diagnosis. The company serves public health authorities, NGOs, and clinical labs. It was incorporated in 1992 and is headquartered in Ireland.
| Indicator | Value |
|---|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 100.0 |